Trials / Not Yet Recruiting
Not Yet RecruitingNCT06093568
Delving Into Participation Trends in Renal Cell Carcinoma Studies
Exploring Engagement Dynamics Among Individuals Impacted by Renal Cell Carcinoma
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Power Life Sciences Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study seeks to delve into the firsthand experiences of patients diagnosed with renal cell carcinoma who partake in a separate clinical study featuring a specific medical intervention. The primary emphasis will be on meticulously tracking the rates of trial completion and withdrawal among these individuals. By joining this clinical trial, individuals have the unique opportunity to contribute to the betterment of future renal cell carcinoma patients and play an active role in advancing clinical research.
Conditions
Timeline
- Start date
- 2024-11-01
- Primary completion
- 2025-11-01
- Completion
- 2026-11-01
- First posted
- 2023-10-23
- Last updated
- 2023-10-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06093568. Inclusion in this directory is not an endorsement.